PRAX PRAXIS PRECISION MEDICINES I revenue, earnings and financials

For the quarter ended June 30, 2026, PRAXIS PRECISION MEDICINES I reported revenue of n/a, net income of −$83.7M and diluted EPS of −$2.87; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.

PRAX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$326M, net income −$303M (margin n/a), EPS −$13.48
• Fiscal year ended Dec 2024: revenue $8.55M, gross profit n/a, operating income −$200M, net income −$183M (margin -2139.6%), EPS −$10.21
• Fiscal year ended Dec 2023: revenue $2.45M, gross profit n/a, operating income −$126M, net income −$123M (margin -5026.6%), EPS −$18.69
• Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$215M, net income −$214M (margin n/a), EPS −$69.65
• Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$167M, net income −$167M (margin n/a), EPS −$3.94

PRAX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue n/a, net income −$83.7M, EPS −$2.87
• Quarter ended Mar 31, 2026: revenue n/a, net income −$92.6M, EPS −$3.20
• Quarter ended Dec 31, 2025 (from the annual report): revenue $0 (down 100.0% year over year), net income −$88.6M, EPS −$3.52
• Quarter ended Sep 30, 2025: revenue $0 (down 100.0% year over year), net income −$73.9M, EPS −$3.36
• Quarter ended Jun 30, 2025: revenue $0 (down 100.0% year over year), net income −$71.1M, EPS −$3.31
• Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$69.3M, EPS −$3.29
• Quarter ended Dec 31, 2024 (from the annual report): revenue $7.46M (up 1349.1% year over year), net income −$58.7M, EPS −$2.88
• Quarter ended Sep 30, 2024: revenue $302K (down 35.5% year over year), net income −$51.9M, EPS −$2.75
• Quarter ended Jun 30, 2024: revenue $357K (down 54.3% year over year), net income −$32.7M, EPS −$1.74
• Quarter ended Mar 31, 2024: revenue $431K (down 36.9% year over year), net income −$39.6M, EPS −$2.84
• Quarter ended Dec 31, 2023 (from the annual report): revenue $515K, net income −$26.9M, EPS $1.99
• Quarter ended Sep 30, 2023: revenue $468K, net income −$24.6M, EPS −$2.72
• Quarter ended Jun 30, 2023: revenue $781K, net income −$34.3M, EPS −$7.38
• Quarter ended Mar 31, 2023: revenue $683K, net income −$37.5M, EPS −$10.58
• Quarter ended Dec 31, 2022 (from the annual report): revenue $0, net income −$41.2M, EPS −$65.86
• Quarter ended Sep 30, 2022: revenue $0, net income −$43.9M, EPS −$0.96
• Quarter ended Jun 30, 2022: revenue $0, net income −$60.2M, EPS −$1.32
• Quarter ended Mar 31, 2022: revenue $0, net income −$68.7M, EPS −$1.51
• Quarter ended Dec 31, 2021: revenue n/a, net income −$58.6M, EPS −$1.35
• Quarter ended Sep 30, 2021: revenue n/a, net income −$44.7M, EPS −$1.00

PRAX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$249M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$132M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$111M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$185M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$125M, share buybacks n/a

PRAX balance sheet

• Jun 30, 2026: cash $475M, total assets $1.39B, total liabilities $49.1M, shareholders' equity $1.34B
• Mar 31, 2026: cash $536M, total assets $1.46B, total liabilities $50.2M, shareholders' equity $1.41B
• Dec 31, 2025: cash $357M, total assets $938M, total liabilities $59.8M, shareholders' equity $878M
• Sep 30, 2025: cash $150M, total assets $396M, total liabilities $52.9M, shareholders' equity $344M
• Jun 30, 2025: cash $157M, total assets $453M, total liabilities $48.6M, shareholders' equity $404M
• Mar 31, 2025: cash $166M, total assets $479M, total liabilities $39.5M, shareholders' equity $439M
• Dec 31, 2024: cash $215M, total assets $483M, total liabilities $37.7M, shareholders' equity $445M
• Sep 30, 2024: cash $169M, total assets $416M, total liabilities $33.6M, shareholders' equity $383M

What is PRAX's revenue?

PRAXIS PRECISION MEDICINES I reported $0 of revenue for the fiscal year ended December 2025.

Is PRAX profitable?

No. PRAXIS PRECISION MEDICINES I lost $339M over the last four quarters.

What is PRAX's EPS?

Diluted earnings per share over the last four quarters were −$12.95; −$2.87 in the latest quarter.

PRAX ownership and insider trades · All stocks